• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患儿临床肺清除指数的纵向病程。

Longitudinal course of clinical lung clearance index in children with cystic fibrosis.

机构信息

Pediatric Respiratory Medicine, Dept of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

出版信息

Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.02686-2020. Print 2021 Jul.

DOI:10.1183/13993003.02686-2020
PMID:33361098
Abstract

BACKGROUND

Although the lung clearance index (LCI) is a sensitive marker of small airway disease in individuals with cystic fibrosis (CF), less is known about longitudinal changes in LCI during routine clinical surveillance. Here, our objectives were to describe the longitudinal course of LCI in children with CF during routine clinical surveillance and assess influencing factors.

METHODS

Children with CF aged 3-18 years performed LCI measurements every 3 months as part of routine clinical care between 2011 and 2018. We recorded clinical data at every visit. We used a multilevel mixed effect model to determine changes in LCI over time and identify clinical factors that influence LCI course.

RESULTS

We collected LCI measurements from 1204 visits (3603 trials) in 78 participants, of which 907 visits had acceptable LCI data. The average unadjusted increase in LCI for the entire population was 0.29 (95% CI 0.20-0.38) LCI units·year. The increase in LCI was more pronounced in adolescence (0.41 (95% CI 0.27-0.54) LCI units·year). Colonisation with either or , pulmonary exacerbations, CF-related diabetes and bronchopulmonary aspergillosis were associated with a higher increase in LCI over time. Adjusting for clinical risk factors reduced the increase in LCI over time to 0.24 (95% CI 0.16-0.33) LCI units·year.

CONCLUSIONS

LCI measured during routine clinical surveillance is associated with underlying disease progression in children with CF. An increased change in LCI over time should prompt further diagnostic intervention.

摘要

背景

虽然肺清除指数(LCI)是囊性纤维化(CF)患者小气道疾病的敏感标志物,但在常规临床监测期间,LCI 的纵向变化知之甚少。在此,我们的目的是描述 CF 儿童在常规临床监测期间 LCI 的纵向变化,并评估影响因素。

方法

2011 年至 2018 年间,年龄在 3-18 岁的 CF 儿童每 3 个月进行一次 LCI 测量,作为常规临床护理的一部分。我们在每次就诊时记录临床数据。我们使用多水平混合效应模型来确定 LCI 随时间的变化,并确定影响 LCI 过程的临床因素。

结果

我们从 78 名参与者的 1204 次就诊(3603 次试验)中收集了 LCI 测量值,其中 907 次就诊有可接受的 LCI 数据。整个人群未经调整的 LCI 平均增加值为 0.29(95%CI 0.20-0.38)LCI 单位·年。青春期 LCI 的增加值更为明显(0.41(95%CI 0.27-0.54)LCI 单位·年)。或 定植、肺部恶化、CF 相关糖尿病和支气管曲霉病与 LCI 的增加呈正相关。调整临床危险因素后,LCI 的年增长率降至 0.24(95%CI 0.16-0.33)LCI 单位·年。

结论

在常规临床监测期间测量的 LCI 与 CF 儿童的潜在疾病进展相关。LCI 随时间的变化增加应促使进一步进行诊断干预。

相似文献

1
Longitudinal course of clinical lung clearance index in children with cystic fibrosis.囊性纤维化患儿临床肺清除指数的纵向病程。
Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.02686-2020. Print 2021 Jul.
2
Pulmonary exacerbations, airway pathogens, and long-term course of lung clearance index in children and young adults with cystic fibrosis.肺脏恶化、气道病原体与肺清除指数在儿童和青年囊性纤维化患者中的长期病程。
Pediatr Pulmonol. 2022 Dec;57(12):3069-3076. doi: 10.1002/ppul.26136. Epub 2022 Sep 14.
3
Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.患有囊性纤维化的学龄前患者的肺部疾病进展
Am J Respir Crit Care Med. 2017 May 1;195(9):1216-1225. doi: 10.1164/rccm.201610-2158OC.
4
Variability of clinically measured lung clearance index in children with cystic fibrosis.囊性纤维化患儿临床测量肺清除指数的可变性。
Pediatr Pulmonol. 2023 Jan;58(1):197-205. doi: 10.1002/ppul.26180. Epub 2022 Nov 2.
5
Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index.早期囊性纤维化肺病通过支气管肺泡灌洗和肺清除指数检测。
Am J Respir Crit Care Med. 2012 Apr 15;185(8):862-73. doi: 10.1164/rccm.201109-1631OC. Epub 2012 Feb 9.
6
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.肺清除指数与磁共振成像在儿童囊性纤维化肺部疾病评估中的比较。
Am J Respir Crit Care Med. 2017 Feb 1;195(3):349-359. doi: 10.1164/rccm.201604-0893OC.
7
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis.肺清除率指数可追踪学龄期囊性纤维化患儿的急性呼吸道事件。
Am J Respir Crit Care Med. 2021 Apr 15;203(8):977-986. doi: 10.1164/rccm.202006-2433OC.
8
Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis.肺清除指数监测学龄前囊性纤维化患儿肺部加重期的治疗反应。
Thorax. 2018 May;73(5):451-458. doi: 10.1136/thoraxjnl-2017-210979. Epub 2018 Feb 15.
9
Change in lung clearance index with microbiological status in children with cystic fibrosis.肺清除指数随囊性纤维化患儿微生物状态的变化。
Pediatr Pulmonol. 2019 Jun;54(6):729-736. doi: 10.1002/ppul.24278. Epub 2019 Mar 5.
10
Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.肺清除指数测定囊性纤维化患儿肺部疾病进展的决定因素。
Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.03380-2020. Print 2021 Jul.

引用本文的文献

1
Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for and a minimal function mutation: results from a 96-week open-label extension study.依列卡福妥/替扎卡福妥/依伐卡托治疗年龄≥6岁、携带CFTR基因杂合突变且有最小功能突变的囊性纤维化儿童:一项96周开放标签扩展研究的结果
Eur Respir J. 2025 Jul 14;66(1). doi: 10.1183/13993003.02435-2024. Print 2025 Jul.
2
Multiple-breath washout to detect lung disease in patients with inborn errors of immunity.多次呼吸洗脱法用于检测免疫缺陷病患者的肺部疾病。
ERJ Open Res. 2024 Mar 11;10(2). doi: 10.1183/23120541.01019-2023. eCollection 2024 Mar.
3
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry.
氧疗与囊性纤维化自然疾病进展的关联:欧洲囊性纤维化协会患者登记处的多状态模型
Ther Clin Risk Manag. 2023 Mar 13;19:255-267. doi: 10.2147/TCRM.S391476. eCollection 2023.
4
Isolated abnormal FEF75% detects unsuspected bronchiolar obstruction in CF children.孤立性异常 FEF75% 在 CF 患儿中检测出未被怀疑的小气道阻塞。
Pediatr Res. 2023 Sep;94(3):1051-1056. doi: 10.1038/s41390-023-02532-2. Epub 2023 Mar 13.
5
The Clinical Association between and Respiratory Outcomes in Adolescents and Adults with Cystic Fibrosis.囊性纤维化青少年和成人中 与呼吸系统结局的临床关联。
Ann Am Thorac Soc. 2023 Jul;20(7):984-992. doi: 10.1513/AnnalsATS.202210-852OC.
6
Breath detection algorithms affect multiple-breath washout outcomes in pre-school and school age children.呼吸检测算法会影响学龄前和学龄儿童的多次呼吸冲洗结果。
PLoS One. 2022 Oct 14;17(10):e0275866. doi: 10.1371/journal.pone.0275866. eCollection 2022.
7
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.依伐卡托钠/泰比卡托钠/埃他卡托钠在 和最小功能突变杂合子且年龄在 6 至 11 岁的囊性纤维化儿童中的疗效和安全性:一项 3b 期、随机、安慰剂对照研究。
Am J Respir Crit Care Med. 2022 Dec 1;206(11):1361-1369. doi: 10.1164/rccm.202202-0392OC.
8
Clinical Impact of in Children with Cystic Fibrosis.对囊性纤维化患儿的临床影响
Microorganisms. 2022 Mar 29;10(4):739. doi: 10.3390/microorganisms10040739.
9
Lung clearance index to characterize clinical phenotypes of children and adolescents with cystic fibrosis.肺清除指数用于表征儿童和青少年囊性纤维化的临床表型。
BMC Pulm Med. 2022 Apr 1;22(1):122. doi: 10.1186/s12890-022-01903-5.
10
The Relation between Vitamin D Level and Lung Clearance Index in Cystic Fibrosis-A Pilot Study.囊性纤维化患者维生素D水平与肺清除指数的关系——一项初步研究
Children (Basel). 2022 Mar 1;9(3):329. doi: 10.3390/children9030329.